SAN FRANCISCO, CA—March 9, 2011—The Gladstone Institutes, a leading biomedical-research organization, today announced its participation in a bold new consortium intended to help the global community better identify, prevent and treat outbreaks of new or re-emerging viruses. Dr.
Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
Julie Langelier, Science Writer and Public Relations Specialist
Direct line: 415.734.5000
Megan McDevitt, Vice President of Communications
Direct line: 415.734.2019
SAN FRANCISCO, CA—December 16, 2010—The Massachusetts General Hospital (MGH) announced today that Shinya Yamanaka, MD, PhD, will receive the 2011 Warren Triennial Prize. Dr. Yamanaka discovered a method to convert adult cells into cells with characteristics of embryonic stem cells.
SAN FRANCISCO, CA—December 1, 2010—For the AIDS community, Thanksgiving came a bit early this year, and after many difficult years, three announcements give hope and reason for celebration during this year's World AIDS Day.
SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Neurological Disease (GIND) in San Francisco have discovered a new strategy to prevent memory deficits in a mouse model of Alzheimer's disease.
SAN FRANCISCO, CA—Scientists at Gladstone Institute of Virology and Immunology have solved a long-standing mystery about HIV infection—namely how HIV promotes the death of CD4 T cells. It is the loss of this critical subset of immune cells that leads to the development of AIDS.
San Francisco, CA—In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofov
SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Neurological Disease (GIND) have offered new information about the events that underlie the “spread” of Alzheimer's disease throughout the brain.
SAN FRANCISCO, CA—November 2, 2010—A new center called the National Resource for Network Biology (NRNB) will help researchers and clinicians analyze an ever-growing wealth of complex biological data and apply that knowledge to real problems and diseases.
SAN FRANCISCO, CA—Alzheimer's disease is an extremely complicated disease. Several proteins seem to be involved in its cause and progression.
SAN FRANCISCO, CA—October 10, 2010—Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have found that an enzyme associated with the storage of fat in the liver is required for the infectious activity of the hepatitis C virus (HCV).